Font Size: a A A

Clinical Study Of Jiawei Chaihu Shugan Powder In The Treatment Of Gastrointestinal Dysfunction In Patients After Laparoscopic Cholecystectomy

Posted on:2022-08-26Degree:MasterType:Thesis
Country:ChinaCandidate:S Y SunFull Text:PDF
GTID:2514306554995299Subject:Traditional Chinese Medicine
Abstract/Summary:PDF Full Text Request
Purpose:This topic aims to observe the clinical efficacy of Jiawei Chaihu Shugan Powder in treating gastrointestinal dysfunction(Stagnation of Liver Qi)in patients after laparoscopic cholecystectomy(LC).Material and method:The cases included in the clinical observation were selected from the Department of Integrated Traditional Chinese and Western Medicine Surgery,Affiliated Hospital of Liaoning University of Traditional Chinese Medicine.From January2019 to December 2020,LC was performed due to chronic calculous cholecystitis and gastrointestinal dysfunction occurred after the operation.A total of 60 patients were diagnosed with liver-stagnation and qi stagnation syndrome by Chinese medicine;60 patients were randomly divided into treatment group and control group,30 cases in each;the control group received routine anti-inflammatory,fluid rehydration,and correction of electrolyte imbalance after LC operation After the gastrointestinal dysfunction occurs,the patients with gastrointestinal dysfunction will be given symptomatic treatment by western medicine;the treatment group will be given 100 m L of Jiawei Chaihu Shugansan Decoction twice a day for those with gastrointestinal dysfunction on the basis of conventional Western medicine treatment after surgery.Stop taking the medicine until gastrointestinal function returns to normal.Monitor and record the symptoms and signs of abdominal distension,nausea,vomiting,gas and bowel sounds,and bowel sounds at 12 h,24h,36 h,48h,60 h,72h after the onset of symptoms,as well as the patient's CRP value and gastrointestinal dysfunction at the time of enrollment.CRP value analysis to judge the overall recovery of gastrointestinal function of the two groups of test patients,so as to evaluate the difference in clinical efficacy of the two groups of treatment methods.Results:1.The first defecation time of the treatment group was 31.50±13.35 h earlier than the control group 50.10±14.22h;the first defecation time of the treatment group was 40.47±13.65 h,which was earlier than the control group 62.57±14.19h;the comparison between the two groups was statistically significant(P<0.05).2.After the occurrence of gastrointestinal dysfunction,the CRP levels of the treatment group and the control group were significantly higher than normal,and there was no statistical difference between the two groups(P>0.05);after the symptoms were relieved,the CRP levels of the treatment group and the control group returned to normal The difference between the two groups was not statistically significant(P>0.05).Comparing the CRP recovery time of the two groups,it was found that the recovery time of the treatment group was 63.60±7.15 h,which was significantly lower than that of the control group 65.60±6.09h(P<0.05).3.At 12 to 48 hours after the occurrence of gastrointestinal dysfunction,the number of patients with bowel sounds in the treatment group was significantly different than that in the control group,and the difference was statistically significant(P<0.05).The bowel sounds in the two groups were 60 to 72 hours.There was no statistically significant difference in the number of recovered patients(P > 0.05),and at 12 h,24h,36 h,and 48 h,the number of patients with bowel sounds returned to normal in the treatment group was more than that in the control group,and the difference was statistically significant(P<0.05).4.Comparing the levels of nausea and vomiting between the two groups of patients at 12 to48 hours after the occurrence of gastrointestinal dysfunction,the difference between the two groups was statistically significant(P <0.05).The number of patients with grade 0 in the treatment group was more than that in the control group,while I-IV The number of patients in grades was less than that in the control group,and the difference was statistically significant(P<0.05);at 48 to 60 hours,the nausea and vomiting symptoms of the two groups basically disappeared,and the difference was not statistically significant(P>0.05);60?72h,the nausea and vomiting symptoms of the two groups of patients disappeared,and the difference was not statistically significant(P>0.05).5.The abdominal distension scores of the two groups were significantly different at 12-48 h after the onset of symptoms,and the difference was statistically significant(P<0.05);there was no statistically significant difference between the two groups at 60-72 h after the onset of symptoms(P>0.05).6.In the treatment group,the cured patients accounted for 16.67%,and the markedly effective patients accounted for 60.00%;the cured patients in the control group accounted for 6.67%,and the markedly effective patients accounted for 33.33%;the total marked efficiency of the two groups was compared,the treatment group was 76.67% higher than the control group by40%.The difference was statistically significant(P<0.05).Conclusion:Patients with gastrointestinal dysfunction after LC can take Jiawei Chaihu Shugan Powder,which can speed up the time of first gas and bowel movement,increase bowel movement,reduce nausea,vomiting,abdominal distension and other symptoms,and also improve CRP levels and reduce The inflammatory response of the intestine is accelerated,the recovery of gastrointestinal function of the patient is accelerated,and a certain basis is provided for the application of Chinese medicine in the perioperative period to accelerate the recovery of the patient.
Keywords/Search Tags:Jiawei Chaihu Shugan Powder, LC postoperative, gastrointestinal dysfunction, liver stagnation and qi stagnation syndrome
PDF Full Text Request
Related items
The Clinical Observation Of Chaihu Shugan Powder Jiawei Fang On Persistent Postural-Perceptual Dizziness Of Liver Depression And Qi Stagnation Type
Clinical Observation On The Effect Of Chaihu Shugan Powder Combined With Artificial Tear In Treating Dry Eye With Qi - Qi Stagnation
Clinical Study Of Chaihu Shugan Powder In The Treatment Of Slow Transit Constipation (liver Stagnation And Qi Stagnation Syndrome)
Based On The "prescription And Syndrome Correlation", Explore The Hemorheological State Of The Liver-stagnation Syndrome Model Rats And The Intervention Effect Of Chaihu Shugan Powder
Effect Observation Of Chaihu Shugan Powder Combined With Electroencephalogram Bionic Electric Stimulation Instrument In The Treatment Of Post-Stroke Depression(Liver Qi Stagnation Syndrome)
The Study On The Central Regulation Mechanism Of Chaihu-Shugan Powder Influencing On The Therapeutic Effect Of Treating For Liver-Qi Stagnation-Type Psychological Erectile Dysfunction
Clinical Efficacy Of Chaihu Shugan Powder In The Treatment Of Liver Qi Stagnation After Intervention Of Hepatocellular Carcinoma
Clinical Observation Of Modified Chaihu Shugan Powder In The Treatment Of Perimenopausal Women With Functional Constipation (Stagnation Of Liver Qi And Spleen Deficiency)
Clinicalobservation On The Effect Of Chaihu Shugan Powder Combined With Pink Siwu Decoction On Qi Stagnation And Blood Stasis After Liver Cancer Tace Operation
10 The Clinical Study On The Treatment Of Erectile Dysfunction Of Liver Qi Stagnation Type With "Qi Machine Ascending And Descending" Theory